Nephrocalcinosis describes the diffuse deposition of calcium salts within the renal parenchyma (medulla and/or cortex). The medullary type is most common (98%) and is characterized by bilateral symmetrical calcification of the renal pyramids. Etiologies include hyperparathyroidism, renal tubular acidosis (RTA), medullary sponge kidney, sarcoidosis, hypercalcemia, and hyperoxaluria. Cortical nephrocalcinosis is rare and associated with acute cortical necrosis, chronic glomerulonephritis, and oxalosis. Diagnosis is usually incidental on imaging; the clinical significance lies in identifying the underlying cause and assessing the risk of nephrolithiasis.
Age Range
20-80
Peak Age
50
Gender
Equal
Prevalence
Uncommon
Nephrocalcinosis results from the precipitation of calcium phosphate (hydroxyapatite) or calcium oxite crystals within the renal parenchyma. In the medullary type, calcium salts accumulate in the thin descending limb of the loop of Henle and collecting ducts; the high salt concentration and low pH in these regions facilitate crystallization. Hyperparathyroidism is the most common etiological factor, causing hypercalcemia and consequent hypercalciuria through increased bone resorption. In renal tubular acidosis (particularly Type 1 — distal RTA), alkalinization of urine facilitates calcium phosphate precipitation. In medullary sponge kidney, ectatic collecting ducts promote stasis and accumulation of calcium crystals. In cortical nephrocalcinosis, calcium is deposited directly in the renal cortex due to cortical necrosis or oxalate deposition. Advanced cases may develop tubulointerstitial damage, renal function loss, and nephrolithiasis.
Bilateral symmetric transformation of normally hypoechoic renal pyramids to markedly hyperechoic appearance on ultrasound is the most diagnostic and commonly described finding for medullary nephrocalcinosis. In clinical practice, nephrocalcinosis is most often detected by this characteristic ultrasound finding. The term Anderson-Carr kidneys specifically describes the complete hyperechoic filling of all pyramids in advanced medullary nephrocalcinosis.
Non-contrast CT demonstrates symmetric punctate or diffuse hyperdense calcifications in the renal pyramids of both kidneys. Densities typically range 100-300 HU and show pyramidal configuration. In early stages, fine calcifications may be limited to the pyramid tips (papillae), while advanced cases show complete pyramidal filling.
Report Sentence
Bilateral symmetric hyperdense calcifications are noted in the renal pyramids of both kidneys, consistent with medullary nephrocalcinosis.
Cortical nephrocalcinosis shows peripheral linear tram-track calcifications in the renal cortex. This pattern follows the outer renal contour and develops from cortical necrosis, chronic glomerulonephritis, or oxalosis. It is much rarer than the medullary type (2%) and indicates a serious underlying pathology.
Report Sentence
Bilateral peripheral linear calcifications (tram-track pattern) are noted in the renal cortex, consistent with cortical nephrocalcinosis.
In the nephrographic phase, calcifications become more conspicuous against the contrast-enhancing parenchyma. In early stages, renal parenchymal enhancement is preserved, indicating maintained functional capacity. In advanced stages, decreased enhancement and cortical thinning may develop, reflecting chronic kidney damage.
Report Sentence
Renal parenchymal enhancement is preserved in the nephrographic phase, with pyramidal calcifications clearly delineated from surrounding parenchyma.
The most characteristic ultrasound finding is the renal pyramids becoming markedly hyperechoic, losing their normal hypoechoic appearance. In early stages, fine hyperechoic foci are seen at the pyramid tips, while advanced stages show complete hyperechoic filling of the pyramids. Acoustic shadowing is present behind significant calcifications. Bilateral and symmetric involvement is typical.
Report Sentence
Renal pyramids of both kidneys demonstrate diffuse hyperechoic appearance with posterior acoustic shadowing; findings are consistent with medullary nephrocalcinosis.
Doppler ultrasound demonstrates generally preserved renal arterial and venous flow. The resistive index (RI) is within normal limits (0.55-0.70) in early stages. In advanced stages, elevated RI (>0.70) may be observed due to tubulointerstitial damage, indicating chronic kidney injury. Twinkling artifact may be seen behind calcified pyramids as bright color mosaic on color Doppler.
Report Sentence
Doppler examination shows preserved renal vascularity with twinkling artifact noted over calcified pyramids.
On T1-weighted sequences, calcified pyramids demonstrate low signal intensity. Calcium salts form crystalline structures with very low proton density, causing signal loss on both T1 and T2. However, MRI is less sensitive than CT for detecting calcifications and is generally not used as a primary diagnostic modality.
Report Sentence
Low signal intensity is noted in the renal pyramids of both kidneys on T1-weighted sequences, which may be consistent with nephrocalcinosis.
On T2-weighted sequences, calcified pyramids show markedly low signal. While normal pyramids have relatively high T2 signal intensity (due to tubular fluid content), calcification suppresses T2 signal, causing hypointense appearance. This contrast allows calcifications to be best appreciated on T2 sequences on MRI. Susceptibility-weighted imaging (SWI) may additionally show blooming artifact.
Report Sentence
Bilateral markedly hypointense areas are noted in the renal pyramids on T2-weighted sequences, consistent with nephrocalcinosis.
In nephrocalcinosis associated with medullary sponge kidney, small cystic areas (ectatic collecting ducts) may be seen within the hyperechoic pyramids. This pattern is described as a 'paintbrush' appearance. The coexistence of both cystic and calcified components within the pyramids helps distinguish medullary sponge kidney from other causes of nephrocalcinosis.
Report Sentence
Small cystic areas are noted within the hyperechoic pyramids, a pattern consistent with nephrocalcinosis in the setting of medullary sponge kidney.
Criteria
Calcifications localized to renal pyramids (medulla); comprises 98% of all nephrocalcinosis cases
Distinct Features
Symmetric calcifications in pyramidal configuration on CT, hyperechoic pyramids on US. Most common causes: hyperparathyroidism (40%), renal tubular acidosis (20%), medullary sponge kidney (20%). Begins at pyramid tips in early stages, progresses to involve entire pyramid.
Criteria
Calcifications localized to renal cortex; comprises 2% of all cases; indicates serious underlying pathology
Distinct Features
Tram-track pattern following outer renal contour on CT. Causes: acute cortical necrosis (most common — obstetric complications, sepsis), chronic glomerulonephritis, oxalosis (primary/secondary), organ rejection. Prognosis is worse than medullary type.
Criteria
Calcification in both medullary pyramids and cortex; very rare, usually in the setting of oxalosis or advanced hyperparathyroidism
Distinct Features
CT shows both pyramidal and peripheral calcification patterns coexisting. May be seen in primary hyperoxaluria and long-term dialysis patients. Diffuse parenchymal calcification indicates advanced renal failure.
Criteria
Medullary nephrocalcinosis + ectatic collecting ducts; may be unilateral or bilateral; frequently accompanied by nephrolithiasis
Distinct Features
Classic 'paintbrush' appearance on IVP — contrast pooling in ectatic collecting ducts. Cystic areas within hyperechoic pyramids on US. Papillary calcifications + peripyramidal cystic changes on CT. Typically presents with recurrent stone formation in young adults.
Distinguishing Feature
Simple cysts are anechoic, thin-walled focal lesions with posterior acoustic enhancement. Nephrocalcinosis shows diffuse hyperechogenicity and acoustic shadowing in pyramids — not a focal cystic lesion. Simple cysts are typically cortical, while nephrocalcinosis diffusely involves medullary pyramids.
Distinguishing Feature
Renal infarct shows a wedge-shaped perfusion defect on contrast-enhanced CT and is usually unilateral. Nephrocalcinosis presents as bilateral symmetric pyramidal calcification on non-contrast CT without perfusion defects. Acute infarct demonstrates loss of enhancement while nephrocalcinosis shows calcification — two entirely different findings.
Distinguishing Feature
Focal pyelonephritis presents with segmental or wedge-shaped decreased enhancement on contrast CT, perinephric fat stranding, and clinical infection signs (fever, leukocytosis). Nephrocalcinosis shows bilateral symmetric pyramidal calcification on non-contrast CT, no perinephric changes, and is usually asymptomatic. Calcification is not expected in pyelonephritis.
Distinguishing Feature
Differentiation from nephrolithiasis (kidney stones) is important: nephrolithiasis forms focal calculi in the collecting system (pelvicalyceal), while nephrocalcinosis is diffuse calcium deposition in the renal parenchyma (pyramids or cortex). On CT, stones are localized round/oval hyperdense foci in the collecting system lumen, while nephrocalcinosis is diffuse calcification in pyramidal configuration. Both conditions may coexist.
Urgency
routineManagement
medicalBiopsy
Not NeededFollow-up
6-monthNephrocalcinosis is usually an incidental imaging finding, and clinical management is directed at the underlying cause. Parathyroidectomy for hyperparathyroidism, alkali therapy for RTA, and treatment of the underlying cause of hypercalcemia are indicated. Renal function (creatinine, GFR) and serum calcium, phosphate, parathyroid hormone levels should be regularly monitored. Due to high nephrolithiasis risk, increased fluid intake and dietary modifications are recommended. Advanced cases may progress to chronic kidney disease; therefore, 6-month interval ultrasound and renal function monitoring is advised.
Nephrocalcinosis is a manifestation of underlying metabolic disease, and treatment is directed at correcting the cause. Hyperparathyroidism (most common cause) can be treated with parathyroidectomy. Advanced cases may lead to chronic kidney disease. Associated nephrolithiasis may cause urinary obstruction. Etiological investigation (serum calcium, PTH, urine calcium, oxalate, citrate, pH) is mandatory.